#	Standard Interpretations
1	07/13/2012 - 1910.1030(c)(1)(v) - Applicability of the Bloodborne Pathogens standard during transection of the umbilical cord.
2	11/24/2008 - 1910.1030(c)(1)(v) - OSHA's position on the use of Novartis' Fluvirin device.
3	03/02/2007 - 1910.1030(c)(1)(v) - Requirements for safety-engineered sharps for stockpiled pandemic influenza vaccines and pre-filled syringes.
4	09/01/2004 - 1910.1030(c)(1)(v) - Limiting factors for implementing the use of engineering controls, i.e., safety scalpels, under the Bloodborne Pathogens standard.
5	05/27/2004 - 1910.1030(c)(1)(v) - Bloodborne Pathogens Standard application to bifurcated needles; acceptability and appropriateness of safety bifurcated needles.
6	04/20/2004 - 1910.1030(c)(1)(v) - Clarification from OSHA regarding the use of the NeedleguardTM in a hospital environment.
7	03/19/2003 - 1910.1030(c)(1)(v) - Engineering control requirements for allergy and immunization injections.
8	02/20/2003 - 1910.1030(c)(1)(v) - Needlestick Safety and Prevention Act and the requirement to include safety-engineered sharps devices in pre-packaged surgical kits or trays.
9	11/21/2002 - 1910.1030(c)(1)(v) - Safer medical devices must be selected based on employee feedback and device effectiveness, not Group Purchasing Organizations.